Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

ASH 2019: Liquid Biopsies? Tumor DNA in Blood Could Predict Early Outcomes in Relapsed or Refractory Myeloma

At the 2019 American Society of Hematology (ASH) Meeting in Orlando, a group of investigators from several institutions including: Harvard Medical School, Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, Massachusetts General Hospital, Newton-Wellesley Hospital, the University of Rochester, and the University of Michigan presented a prize winning poster entitled Circulating Tumor Dna in [...]



This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here

Share the post

ASH 2019: Liquid Biopsies? Tumor DNA in Blood Could Predict Early Outcomes in Relapsed or Refractory Myeloma

×

Subscribe to Page Not Found - The Myeloma Crowd

Get updates delivered right to your inbox!

Thank you for your subscription

×